Carregant...
Acquired Resistance to Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICI) have rapidly altered the treatment landscape for multiple tumor types, providing unprecedented survival in some patients. Despite the characteristic durability of response to ICI, unfortunately many patients with initial response will later develop acquired resista...
Guardat en:
| Publicat a: | Cancer Cell |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7182070/ https://ncbi.nlm.nih.gov/pubmed/32289269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2020.03.017 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|